“Delivery of this report will take 1-3 days after purchase.”

The Public Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

Report scope

Public Health Deals and Alliances of 2014 is intended to provide the reader with an in-depth understanding and access to parthering trends and structure of deals entered into by leading companies worldwide.

Public Health Deals and Alliances of 2014 includes:

• Trends in dealmaking in the biopharma industry during 2014
• Comprehensive directory of partnering deals in 2014
• Links to online access to all deals and alliances
• The leading partnering deals by value in 2014
• Most active partnering dealmakers during 2014
• Deals by headline value, upfront, milestone and royalty rates

In Public Health Deals and Alliances of 2014 the partnering deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Therapy area
• Technology type

Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.

Benefits

Public Health Deals and Alliances of 2014 provides the reader with the following key benefits:

• In-depth understanding of recent dealmaking trends during 2014
• Comprehensive access to all deals entered into by the world’s biopharma companies during 2014
• Detailed access to actual partnership deals and contracts entered into by the leading fifty big pharma and big biotech companies
• Full listing of Public Health deals by company A-Z, deal type, stage of development, technology and specific therapy focus
• Identify leading Public Health deals by value during 2014
• Identify the most active Public Health dealmakers during 2014
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table of Contents

Executive Summary
Introduction

Chapter 1 - Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 - Average financial deal terms
2.1 Partnering deals with headline values
2.2 Partnering deals with upfront payments
2.3 Partnering deals with milestone payments
2.4 Partnering deals withroyalty rates

Chapter 3 - Leading deals during 2014
3.1. Introduction
3.2. Most active dealmakers
3.3. Top deals by value during 2014
3.4. Big pharma dealmaking activity
3.5. Big biotech dealmaking activity

Chapter 4 - Partnering deals directory 2014
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By stage of development
4.5. By technology type
4.6. By therapy area

About Wildwood Ventures
Current Partnering
Current Agreements

List of Figures

Figure 1: Partnering by deal type during 2014
Figure 2: Partnering by industry sector during 2014
Figure 3: Partnering by stage of development during 2014
Figure 4: Partnering by technology type during 2014
Figure 5: Partnering by therapy area during 2014
Figure 6: Deals with a headline value
Figure 7: Deals with headline value distribution, US$million
Figure 8 Deals with upfront payment values
Figure 9: Deal with upfront payment distribution, US$million
Figure 10: Deals with milestone payments
Figure 11: Deals with royalty rates, %
Figure 12: Active dealmakers in 2014
Figure 13: Top deals by value during 2014
Figure 14: Big pharma - top 50 - January to December 2014
Figure 15: Big pharma deal frequency - 2014
Figure 16: Big biotech - top 50 - January to December 2014
Figure 17: Big biotech deal frequency - 2014